A New Paradigm for Uterine Fibroid Treatment: Transcervical, Intrauterine Sonography-Guided Radiofrequency Ablation of Uterine Fibroids with the Sonata System.

Abstract

PURPOSE OF REVIEW:

This article provides the current evidence related to transcervical radiofrequency ablation of uterine fibroids under integrated intrauterine sonography guidance (the Sonata System).

RECENT FINDINGS:

Published data on the treatment of fibroids with the Sonata System has demonstrated significant median reductions in total (73.3%) and perfused (73.3%) uterine fibroid volume, menstrual bleeding (72.3%), symptom severity (62.5%), and improvements in health-related quality of life (127%) at 12 months post-ablation. A clinical trial under an FDA Investigational Device Exemption is in progress.

SUMMARY:

The Sonata System is a promising treatment modality for uterine fibroids. As an incisionless, minimally invasive treatment that does not require general anesthesia or hospitalization, it has the potential for redefining the current paradigm for management of symptomatic fibroids.

• Authors: David B Toub
• Journal: Current obstetrics and gynecology reports (Curr Obstet Gynecol Rep) Vol. 6 Issue 1 Pg. 67-73 ( 2017) ISSN: 2161-3303 [Print] United States
• PMID: 28357157 (Publication Type: Journal Article, Review)